Skip to Content

CREON 1203 (Creon 15,000 units amylase / 3,000 units lipase / 9,500 units protease)

Generic Name: pancrelipase

Pill with imprint CREON 1203 is White, Capsule-shape and has been identified as Creon 15,000 units amylase / 3,000 units lipase / 9,500 units protease. It is supplied by AbbVie, Inc..

Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 15,000 units amylase / 3,000 units lipase / 9,500 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1203

Creon 15,000 units amylase / 3,000 units lipase / 9,500 units protease CREON 1203

Creon

Generic Name
pancrelipase
Imprint
CREON 1203
Strength
15,000 units amylase / 3,000 units lipase / 9,500 units protease
Color
White
Size
14.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
AbbVie, Inc.
National Drug Code (NDC)
00032-1203
Inactive Ingredients
cetyl alcohol, dimethicone, titanium dioxide, triethyl citrate, hypromellose phthalate (31% phthalate, 40 cst)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.